URISPAS 200 mg, film-coated tablet 42 tablets
Active ingredients: Flavoxate hydrochloride
Commercialized according to BDPM
Film-coated tablet42 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- URISPAS 200 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC-Aluminium de 42 comprimé(s)
- Marketing authorisation holder
- BOUCHARA-RECORDATI
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 24 Oct 2024
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63383409CIP73263409CIP133400932634095Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FLAVOXATE (CHLORHYDRATE DE)comprimé | 200 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.